Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1249294.RAA1GJpBvE6FTuGnR7BQhgC5DpYxA5q2-7hutePiReZvQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1249294.RAA1GJpBvE6FTuGnR7BQhgC5DpYxA5q2-7hutePiReZvQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1249294.RAA1GJpBvE6FTuGnR7BQhgC5DpYxA5q2-7hutePiReZvQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1249294.RAA1GJpBvE6FTuGnR7BQhgC5DpYxA5q2-7hutePiReZvQ130_provenance.
- NP1249294.RAA1GJpBvE6FTuGnR7BQhgC5DpYxA5q2-7hutePiReZvQ130_assertion description "[Expression of the oncogene hepatocyte growth factor receptor (MET) and phosphorylation of the MET protein have been associated with both primary and acquired resistance to tyrosine kinase inhibitors (TKIs) used in therapy targeting the epidermal growth factor receptor (EGFR) in patients with non-small cell lung cancers (NSCLCs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249294.RAA1GJpBvE6FTuGnR7BQhgC5DpYxA5q2-7hutePiReZvQ130_provenance.
- NP1249294.RAA1GJpBvE6FTuGnR7BQhgC5DpYxA5q2-7hutePiReZvQ130_assertion evidence source_evidence_literature NP1249294.RAA1GJpBvE6FTuGnR7BQhgC5DpYxA5q2-7hutePiReZvQ130_provenance.
- NP1249294.RAA1GJpBvE6FTuGnR7BQhgC5DpYxA5q2-7hutePiReZvQ130_assertion SIO_000772 25522678 NP1249294.RAA1GJpBvE6FTuGnR7BQhgC5DpYxA5q2-7hutePiReZvQ130_provenance.
- NP1249294.RAA1GJpBvE6FTuGnR7BQhgC5DpYxA5q2-7hutePiReZvQ130_assertion wasDerivedFrom befree-2016 NP1249294.RAA1GJpBvE6FTuGnR7BQhgC5DpYxA5q2-7hutePiReZvQ130_provenance.
- NP1249294.RAA1GJpBvE6FTuGnR7BQhgC5DpYxA5q2-7hutePiReZvQ130_assertion wasGeneratedBy ECO_0000203 NP1249294.RAA1GJpBvE6FTuGnR7BQhgC5DpYxA5q2-7hutePiReZvQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP1249294.RAA1GJpBvE6FTuGnR7BQhgC5DpYxA5q2-7hutePiReZvQ130_provenance.